We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 714 results
  1. Effects of benztropine analogs on delay discounting in rats

    Rationale

    Methylphenidate and d -amphetamine, medications used for treatment of attention deficit hyperactivity disorder (ADHD), are used...

    Paul L. Soto, Takato Hiranita in Psychopharmacology
    Article 22 September 2020
  2. Motor and non-motor symptoms, drugs, and their mode of action in Parkinson’s disease (PD): a review

    Parkinson’s disease is second most common neurodegenerative disorder neurological illness that primarily affects patients in their later years of...

    Nancy Saini, Neetu Singh, ... Harvinder Singh Sohal in Medicinal Chemistry Research
    Article 07 March 2024
  3. Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth

    The endogenous cholinergic system plays a key role in neuronal cells, by suppressing neurite outgrowth and myelination and, in some cancer cells,...

    Olivier Cerles, Tânia Cristina Gonçalves, ... Frédéric Batteux in Acta Neuropathologica Communications
    Article Open access 18 January 2019
  4. Discovery and Development of Monoamine Transporter Ligands

    Monoamine transporters (MATs) are targets of a wide range of compounds that have been developed as therapeutic treatments for various...
    Shaili Aggarwal, Ole Valente Mortensen in Drug Development in Psychiatry
    Chapter 2023
  5. Anticholinergics

    Reference work entry 2024
  6. Safety of Physostigmine for Pediatric Antimuscarinic Poisoning

    Introduction

    Physostigmine fell out of widespread use in the 1980s due to safety concerns; however, more recent research has demonstrated that its...

    Sarah Huber, Robert Avera, ... Kristine Nañagas in Journal of Medical Toxicology
    Article 24 January 2024
  7. Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia

    Acetylcholine (ACh) signaling is critical for central nervous function and is known to be abnormal in schizophrenia (SZ), a chronic neuropsychiatric...
    Chapter 2022
  8. Trends in Biomarkers of Neurodegenerative Diseases

    An agreed-upon action plan is necessary by national health funding and research agencies over the next decade to lower the number of new cases of...
    Philip V. Peplow, Bridget Martinez, Thomas A. Gennarelli in Neurodegenerative Diseases Biomarkers
    Protocol 2022
  9. A systematic review on the use of clozapine in treatment of tardive dyskinesia and tardive dystonia in patients with psychiatric disorders

    Rationale

    Though clozapine is recommended for treatment of tardive dyskinesia (TD) relating to the use of antipsychotic medications, studies...

    Jocelyn Wong, Tiffanie Pang, ... Sherry Kit Wa Chan in Psychopharmacology
    Article 30 September 2022
  10. Botulinum Toxin Therapy for Autonomic Dysfunction (Excessive Drooling/Sialorrhea and Excessive Sweating (Hyperhidrosis) and for Certain Skin Disorders

    Injection of botulinum toxins to the glands reduces the secretion of saliva or sweat by blocking the release of nerve signal transmitter...
    Bahman Jabbari in Botulinum Toxin Treatment
    Chapter 2024
  11. Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease

    Parkinson's disease (PD) is characterized by oxidative stress and neuroinflammation as key pathological features. Emerging evidence suggests that...

    Deepak Vasudevan Sa**i, Praveen Thaggikuppe Krishnamurthy, ... Ravi Naik Mudavath in Neurochemical Research
    Article 26 January 2024
  12. Pharmacologic therapies of pain in patients with spinal cord injury: a systematic review

    Study design

    Systematic review.

    Objectives

    This systematic review evaluates all randomized clinical trials (RCTs) conducted on assessing the efficacy...

    Mohammad Hossein Asgardoon, Seyed Behnam Jazayeri, ... Vafa Rahimi-Movaghar in Spinal Cord Series and Cases
    Article 04 July 2022
  13. Self-reported periodontitis and C-reactive protein in Parkinson’s disease: a cross-sectional study of two American cohorts

    Periodontitis triggers systemic repercussions, such as elevated levels of high-sensitive C-reactive protein (hs-CRP). This has never been studied...

    Patrícia Lyra, João Botelho, ... José João Mendes in npj Parkinson's Disease
    Article Open access 13 April 2022
  14. Investigations of the Interaction Mechanism Between Orphenadrine Hydrochloride and Bovine Serum Albumin by Spectroscopic and Voltammetric Techniques

    The interaction of orphenadrine hydrochloride (ORD) with the model protein, bovine serum albumin (BSA), was investigated using a variety of...

    Naveen M. Gokavi, Sharanappa T. Nandibewoor, Jayant I. Gowda in Journal of Fluorescence
    Article 28 March 2023
  15. Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats

    Rationale and objectives

    Benztropine (BZT) analogs and other atypical dopamine uptake inhibitors selectively decrease cocaine self-administration at...

    Claudio Zanettini, Derek S. Wilkinson, Jonathan L. Katz in Psychopharmacology
    Article 21 September 2017
  16. Reverse Takotsubo Cardiomyopathy Precipitated by Chronic Cocaine and Cannabis Use

    This case report describes a 31-year-old man with 10 years of cocaine and cannabis dependence who developed reverse Takotsubo cardiomyopathy (rTC), a...

    Emily Nash, Darren M. Roberts, Nazila Jamshidi in Cardiovascular Toxicology
    Article 24 August 2021
  17. Analysis of clinical studies on clozapine from 2012-2022 

    Clozapine has been considered the “gold standard” in the treatment of schizophrenia for many years. Clozapine has a superior effect, particularly in...

    Anton Freibüchler, Roland Seifert in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 25 June 2024
  18. Mycotherapeutics Affecting Dopaminergic Neurotransmission to Exert Neuroprotection

    Alternative or integrative medicine is a holistic approach to healthcare that has been used for centuries in many different cultures. Today, there is...
    Shannon Kim, Rishi M. Nadar, ... Muralikrishnan Dhanasekaran in Mushrooms with Therapeutic Potentials
    Chapter 2023
  19. Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism

    Drug-induced parkinsonism (DIP) can be clinically indistinguishable from degenerative parkinsonism, and bedside assessments are needed to...

    Whitley W. Aamodt, Jacob G. Dubroff, ... James F. Morley in npj Parkinson's Disease
    Article Open access 28 April 2022
Did you find what you were looking for? Share feedback.